CASI Pharmaceuticals, Inc.·4

Jul 3, 9:30 PM ET

SHROTRIYA RAJESH C MD 4

4 · CASI Pharmaceuticals, Inc. · Filed Jul 3, 2018

Insider Transaction Report

Form 4
Period: 2018-06-29
Transactions
  • Award

    Stock Options (Right to Buy)

    2018-06-29+35,00035,000 total
    Exercise: $8.23Exp: 2028-06-29Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]Stock option award will vest ratably quarterly to the end of one year.

Documents

1 file
  • 4
    tv497978_4.xmlPrimary

    OWNERSHIP DOCUMENT